PMA device
Medtronic(R) Capsurefix Lead Model 4068,4067,4568
Medtronic, Inc. · Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN, Class III) · First FDA decision Aug 24, 2016, newest Apr 23, 2020Bradycardia and heart block
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
2
Naming "Medtronic Capsurefix"
MAUDE reports
1
Brand "Medtronic Capsurefix", since 2015
PubMed studies
10
Mentioning "Medtronic Capsurefix"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medtronic(R) Capsurefix Lead Model 4068,4067,4568
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- MEDTRONIC(R) CAPSUREFIX LEAD MODEL 4068,4067,4568PMA supplement
P930039-S202 · Decided Apr 23, 2020 · 297 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN) · Cardiology
- MEDTRONIC(R) CAPSUREFIX LEAD MODEL 4068,4067,4568PMA supplement
P930039-S152 · Decided Oct 25, 2016 · 175 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN) · Cardiology
- MEDTRONIC(R) CAPSUREFIX LEAD MODEL 4068,4067,4568PMA supplement
P930039-S148 · Decided Aug 24, 2016 · 176 days after receipt · Normal 180 Day Track
Device type: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Pacemakers: Single-Chamber and Dual-Chamber Permanent Cardiac PacemakersNational analysisReview closedCAG-00063R3Updated Sep 17, 2026
- Single Chamber and Dual Chamber Permanent Cardiac PacemakersNational determinationOn the books20.8.3Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Medtronic Capsurefix", any status and sponsor, newest update first.
Mayo ClinicAcademic, hospital or other
NCT02145351 · 32 participants · Start Apr 7, 2014 · Primary completion May 9, 2022
Device: Rate adaptive atrial pacing using a dual-chamber pacemaker; Pacemaker system will be implanted but set to Pacing Off. · For: Heart Failure With a Preserved Ejection Fraction; Heart Failure, Diastolic; Chronotropic Incompetence
Sites: Rochester, Minnesota
- Advisa MRI Clinical StudyPivotal-lookingCompleted
Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
NCT01110915 · 269 participants · Start Jun 2010 · Primary completion Mar 2012
Device: Medtronic Advisa MRI Implantable Pulse Generator (IPG); Medtronic CapSureFix MRI™ active fixation MRI lead · For: Magnetic Resonance Imaging; Cardiac Pacemaker, Artificial
Sites: Salinas, California; Orlando, Florida; West Des Moines, Iowa · 37 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medtronic Capsurefix", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code NVN
202,094 reports: 87,136 malfunction, 110,708 injury, 4,019 death
Newest reports for this brand
MW5181010 · Received Dec 22, 2025 · Event dated Nov 12, 2025
Device type: Permanent Pacemaker Electrode (DTB)
Device problem as coded: Difficult to Open or Close
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Medtronic Capsurefix"[tiab]. The summary above synthesizes these.
- Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker.
Hauser RG, Gornick CC, Abdelhadi RH, et al. · Heart Rhythm · 2021
- Detection of high-frequency artifact as a function of pulse generator algorithms and outer-insulation material.
Narui R, Nakamura T, Nakajima I, et al. · Heart Rhythm · 2019
- Inappropriate noise detection in Tendril family pacing leads.
Zhu DWX, Chu MM, Zager AJ, et al. · J Cardiovasc Electrophysiol · 2019Comparative Study
- Complications of Cardiac Perforation and Lead Dislodgement with an MRI-Conditional Pacing Lead: a Korean Multi-Center Experience.
Kwon CH, Choi JH, Kim J, et al. · J Korean Med Sci · 2016Comparative Study, Multicenter Study
- [Comparison of three brands of intracardiac pacemaker leads].
Frangini S P, Vergara S I, González A R, et al. · Rev Med Chil · 2006Comparative Study, English Abstract
- A comparison between passive and active fixation leads in the coronary sinus for biatrial pacing: initial experience.
Levy T, Walker S, Rex S, et al. · Europace · 2000Clinical Trial, Comparative Study
- Left ventricular endocardial pacing: a transarterial approach.
Reinig M, White M, Levine M, et al. · Pacing Clin Electrophysiol · 2007Research Support, Non-U.S. Gov't
- Cardiac perforation and lead dislodgement after implantation of a MR-conditional pacing lead: a single-center experience.
Elmouchi DA, Rosema S, Vanoosterhout SM, et al. · Pacing Clin Electrophysiol · 2014Comparative Study, Research Support, Non-U.S. Gov't
- Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling.
Wilkoff BL, Albert T, Lazebnik M, et al. · Heart Rhythm · 2013Comparative Study
- MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results.
Shenthar J, Milasinovic G, Al Fagih A, et al. · Heart Rhythm · 2015Multicenter Study, Randomized Controlled Trial
Other devices of this type
Also filed under product code NVN.
- CapSureFix Novus LeadMedtronic, Inc. · PMA 2025
- CapSure Sense LeadMedtronic Cardiac Rhythm Disease Management · PMA 2020
- FINELINE II Sterox and Sterox EZ pace/sense leadsBoston Scientific · PMA 2026
- SelectSecure Lead Model 3830Medtronic Cardiac Rhythm Disease Management · PMA 2026
- Medtronic SelectSecure MRI SureScan LeadMedtronic Cardiac Rhythm Disease Management · PMA 2022
- Tendril STSAbbott Medical · PMA 2020
- Tendril, Tendril St, Tendril Sts, and Optisense LeadsAbbott Medical · PMA 2015
- Solia CSP S LeadsBiotronik, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.